Back to newsMonte Rosa Therapeutics target price raised to $19 from $17GGLUE•2026-10-12UBS raised its target price for Monte Rosa Therapeutics to $19 from $17.Related NewsNNasdaq trade halt continues; volatility trading pause at 9:53 a.m.NXGL•2026-10-12GNasdaq trade halt: volatility trading pause at 09:46 AMGIXI•2026-10-12CNasdaq trade halt: volatility trading pause at 09:30 amCOOL•2026-10-12BUS research roundup: Biogen, Datadog, TeslaBIIB•2026-10-12SShattuck Labs gets UBS buy rating with $17 target priceSTTK•2026-10-12
GLUE•GLUE•GLUE•GLUE•
